Phase II trial of irinotecan (CPT-11) plus raltitrexed (ZD) in patients with previously untreated, advanced colorectal cancer (ACC)
Aparicio, J., Vicent, J., Maestu, I., Galán, A., Bosch, C., Busquier, I., Garcerá, S., Llorca, C., Campos, J., Balcells, M.Volume:
37
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(01)81608-7
Date:
April, 2001
File:
PDF, 160 KB
english, 2001